Saturday 7 November 2026 Export PHAT’s income statement to Excel — free account

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $175.1 million, up 216.9% from fiscal 2024.

Revenue: +71.1%
EPS: +60.1%
Free cash flow: +112.2%
Total debt: −20.1%

Quarter to September 2026, against a year earlier

5.23 0.15 +2.95%

Follow PHAT

Alert me

Market cap: $413.0M
P/E: 0.0×
Fwd P/E: −7.5×
Dividend yield: —
F-score: 4/9
Altman Z: −7.89
Beneish M: −1.39
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	21.55%	26.42%	46.58%	63.97%	+8 more TTM periods Free account
ROA Full definition →	(28.36%)	(34.32%)	(52.49%)	(69.41%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(61.92%)	(69.23%)	(103.12%)	(225.78%)
Average Days of Receivables Full definition →	142.88	148.37	143.80	162.85
Free Cash Flow per Share Full definition →	(0.25)	(0.44)	(1.19)	(2.29)
Free Cash Flow Full definition →	(21.04)	(36.91)	(97.76)	(167.00)
Capital Expenditures Full definition →	(0.30)	(0.22)	(0.27)	(0.23)
Other line items
Cash ROIC Full definition →	(855.67%)	(1,322.06%)	(1,282.32%)	168.50%
Accounts Receivable Turnover Full definition →	3.36	3.22	3.50	3.00
Accounts Payable Turnover Full definition →	8.72	8.74	3.43	2.92
Inventory Turnover Full definition →	9.45	7.35	6.38	5.18
Average Days of Payables Full definition →	76.35	47.81	75.26	80.48
Days of Inventory on Hand Full definition →	52.46	68.78	76.95	89.12
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	11.58%	12.56%	15.31%	18.72%
Selling, General and Administrative Expense of Revenue Full definition →	78.36%	87.32%	116.77%	159.74%
Share Based Compensation of Revenue Full definition →	8.65%	11.33%	14.01%	16.40%
Interest Coverage Full definition →	(0.41)	(0.64)	(1.47)	(2.35)
Operating CF/Net income Full definition →	0.25	0.37	0.62	0.75
Depreciation/Fixed assets Full definition →	4.27	3.96	3.67	3.43
Capex/Depreciation Full definition →	(0.08)	(0.06)	(0.07)	(0.06)
Revenue per Share Full definition →	3.24	2.86	2.50	2.40
Operating CF per Share Full definition →	(0.24)	(0.44)	(1.19)	(2.29)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly